Tentarix is a technology company that specializes in providing innovative software solutions aimed at enhancing business processes and customer experiences. The company leverages cutting-edge technologies to deliver products that cater to a diverse clientele across various industries.

Paul Grayson

Margaret Karow

Tentarix

Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage powerful synergistic biology. On an unprecedented scale, we are leading a fundamental change in the methods of discovery and engineering of multi-specific biologics.

https://www.businesswire.com/news/home/20211014005033/en/Tentarix-Biotherapeutics-Emerges-with-50-Million-Series-A

Versant Ventures

Samsara BioCapital

Tentarix Biotherapeutics

Exciting news: Tentarix and AbbVie are joining forces to potentially revolutionize oncology and immunology treatment through conditionally-active multi-specific biologics. Read more about our groundbreaking collaboration: https://lnkd.in/gn2_DhiW

We are #Hiring! Several incredible opportunities are available on our growing team. Currently accepting applications from creative, hands-on, self-directed, excellent communicators to join our team. We offer autonomy, flexibility, a modern culture, and the best tools to ensure individual and collective success. 

Explore all job openings and apply here: https://lnkd.in/gF57EJP8

The excitement around our Tentacles™ platform continues to grow! Today we announced the completion of our Series B financing, bringing total equity and upfront deal consideration to $132 Million.

Catch up on our Series B details here: https://lnkd.in/gM34hP4k

We're #hiring creative, hands-on, self-directed, excellent communicators to join our team. We offer autonomy, flexibility, a modern culture, and the best tools to ensure individual and collective success. We've launched some exciting news this week too! 

Check out our new collaboration: 
https://lnkd.in/gzXY9dSM

Apply here:
https://lnkd.in/g2eYMRN7

🔬 Delighted to share news of our collaboration, leveraging our Tentacles platform to develop multi-functional, conditional protein therapeutics for oncology and inflammatory diseases! Dive into the details through the link below.
https://lnkd.in/gzXY9dSM

Metric
Company Name	Tentarix
Symbol
MSH ID	COM:TENTARIX
Market	PRIVATE
Sector	Technology
Industry	Software & Technology Solutions
Country	US
Stage
Employee Count	35
Website	tentarix.com
LinkedIn	tentarix-biotherapeutics
Founders

Metric
Market Cap	167M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:TENTARIX

Tentarix

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue